BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6098001)

  • 1. Measurement of concanavalin A-unbound serum pregnancy-specific beta 1-glycoprotein in the assessment of trophoblastic diseases.
    Englebienne P; Doyen G
    Ric Clin Lab; 1984; 14(3):561-3. PubMed ID: 6098001
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
    Horne CH; Rankin R; Bremner RD
    Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant gestational trophoblastic disease.
    Lifshitz S; Outhouse C; Buchsbaum HJ
    J Iowa Med Soc; 1977 Oct; 67(10):391-5. PubMed ID: 198497
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
    Soma H; Kikuchi K; Takayama M; Saegusa H; Saito T; Kashiwagi H; Sayama S
    Arch Gynecol; 1981; 230(4):321-7. PubMed ID: 6269502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational trophoblastic neoplasia. A review of new concepts.
    Campbell B; Magrina JF; Capen CV; Masterson BJ
    J Kans Med Soc; 1983 Feb; 84(2):61-4. PubMed ID: 6300267
    [No Abstract]   [Full Text] [Related]  

  • 10. Gestational trophoblastic diseases. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1983; 692():7-81. PubMed ID: 6318459
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of pregnancy-specific beta 1-glycoprotein analysis in endocrine tests of the gonadal and placental system].
    Mochizuki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():1274-8. PubMed ID: 2560074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and radiological features of gestational trophoblastic tumors].
    Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
    Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy proteins and their use in medicine].
    Fialová L; Malbohan I
    Cesk Fysiol; 1985; 34(5):385-98. PubMed ID: 2415264
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible new markers in trophoblastic diseases.
    Inaba N; Ishige H; Ijichi M; Satoh N; Katoh T; Sekiya S; Shirotake S; Ohkawa R; Takamizawa H; Nitoh A; Renk T; Bohn H
    Am J Obstet Gynecol; 1982 Aug; 143(8):973-4. PubMed ID: 6980595
    [No Abstract]   [Full Text] [Related]  

  • 20. The histopathology of trophoblastic tumours.
    Elston CW
    J Clin Pathol Suppl (R Coll Pathol); 1976; 10():111-31. PubMed ID: 184114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.